01.01.05
Recently Enzymotec, together with Prof. Inna Weiner, Dean of the Faculty of Social Sciences at the Tel Aviv University, presented a clinical study showing a significant effect on the cognitive performance in an elderly rat model generated by using a lipid-based delivery system for DHA. DHA has been known to be one of the prominent building blocks of our brain cells' membrane, according to the company. However, common treatment of cognitive impairment with DHA provides only a marginal effect. One of the reasons lies in its relatively poor bioavailability to the cerebral tissues. In this study, using the chemical agent scopolamine, which accelerates the processes of cognitive aging by inducing amnesia the cognitive abilities of middle-aged rats were impaired. Several groups of rats were fed with traditional sources of DHA while others received novel lipid-based delivery platforms carrying DHA. According to Enzymotec’s director of clinical studies, the company’s new DHA delivery systems empower DHA by increasing its bioavailability to the brain and by performing synergistically with its carrier. As a result, a significant improvement in various cognitive and behavioral patterns such as memory, learning and mood is achieved.